Anthos Therapeutics is led by a world-class executive team highly experienced in the successful development, approval, and commercialization of products across a wide range of therapeutic areas.
Bill Meury is the CEO and a member of the Board of Directors of Anthos Therapeutics. Meury joins after successfully leading KarunaTherapeutics, and brings significant expertise in strategic planning, commercialization, business development and licensing, R&D partnerships and new product launches. Read more here.
MANAGEMENT TEAM
Dan Bloomfield, M.D
Chief Medical Officer
Debra Freedholm
SVP, Clinical Operations
Erika Dahl, Ph.D.
Program Manager
Mike Doremus
Head of Technical Operations
Bill Meury
CEO
Jonathan Freeman, Ph.D
Co-Founder and Chief Operating Officer
Gi Gi Galiano
Vice President Program & Risk Management and Human Resources Operations
Janeen Salter
Director of Clinical Operations
Bruce Hug, M.D., Ph.D
Vice President, Clinical Development
Alisha Lundholm, CPA, MSA
Corporate Controller
Drew Young
Chief Commercial Officer and Head of Patient Experience
David McIntyre B.EC., LL.B., CPA, MBA
Chief Financial Officer
Nik Mehta, Ph.D
Chief Technical and Regulatory Officer
Jessica Patrick Seabrook
Office Operations & Events Manager
CONSULTANTS
Connie Cullen, PH.D
Principal Consultant
Yasser Khder, M.D, PH.D
Founder & Senior Consultant at MYRA Life Science Services
BOARD OF DIRECTORS
Scott Beardsley
Ari Brettman, M.D
Raymond Camahort
Mike Exton
Nicholas Galakatos, Ph.D
Bill Meury
CEO